At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 19, 2026 at 20:00 ET
Corcept Therapeutics CEO Joseph Belanoff sold $1.31M worth of shares in a single open-market transaction. This represents a modest insider sale from the CEO, with no other insiders trading in the past 7 days.
- CEO Joseph Belanoff sold 26,198 shares at $50.0735 per share on March 25, 2026.
- Total value of the sale: $1,311,825.55.
- This transaction was an open-market sale (Form 4 code 'S').
- No other insider trades at CORT in the past 7 days.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access